Omnicell (OMCL)
(Delayed Data from NSDQ)
$27.47 USD
-0.22 (-0.80%)
Updated Mar 18, 2024 04:00 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Price, Consensus and EPS Surprise
OMCL 27.47 -0.22(-0.80%)
Will OMCL be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for OMCL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OMCL
Here's Why You Should Retain Omnicell (OMCL) Stock Now
Omnicell (OMCL) Q4 Earnings Top Estimates, Gross Margin Down
OMCL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Omnicell (OMCL) Tops Q4 Earnings and Revenue Estimates
Here's Why You Should Retain Omnicell (OMCL) Stock Now
Omnicell (OMCL) Gains From Innovation Amid Cost Pressure
Other News for OMCL
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Omnicell’s Steady Demand and Modest Revenue Projections Justify Hold Rating
Omnicell Announces Executive Retirement and New VP Appointment
Omnicell Is Building A Strong Moat
Vivid Seats, Atmus Filtration & Visteon are some of the top small cap value stocks - BofA